Phosphonate compounds
US-9206208-B2 · Dec 8, 2015 · US
US2025340585A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025340585-A1 |
| Application number | US-202218729747-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 22, 2022 |
| Priority date | Jan 21, 2022 |
| Publication date | Nov 6, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An object is to provide an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative suitable for use in synthesis of an acyclic single-stranded polynucleotide comprising diaminopurine and/or a thiouracil derivative by a phosphoramidite method. This object is achieved by an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative protected with a specific protecting group removable by a base.
Opening claim text (preview).
1 . A compound or a salt thereof or a solvate thereof, the compound being represented by formula (1A) or (1B): wherein R 1 and R 2 are the same or different, and each is a hydrogen atom or an organic group; R 3 and R 4 are the same or different, and each is a protecting group for a hydroxyl group; R 5 and R 6 are the same or different, and each is an alkyl group; R 7 , R 8 , R 9 , and R 10 are the same or different, and each is a hydrogen atom or a protecting group removable by a base, excluding a case in which all are hydrogen atoms; and at least one protecting group removable by a base is a group represented by formula (a): wherein R a is a hydrogen atom or an alkyl group, and p is an integer of 1 to 3; R 11 is a hydrogen atom or an alkyl group; n is an integer of 1 to 3; and m is an integer of 0 to 3. 2 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein at least one of R 7 and R 8 is a group represented by formula (a), and at least one of R 9 and R 10 is a group represented by formula (a). 3 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein n is 1, m is 0, R a is a hydrogen atom, and p is 1. 4 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein R 3 is a group represented by formula (b): wherein R 31 , R 32 , and R 33 are the same or different, and each is a hydrogen atom or an alkoxy group, R 4 is —(CH 2 ) 2 —CN, and R 5 and R 6 are isopropyl groups. 5 . A reagent comprising the compound or a salt thereof or a solvate thereof according to claim 1 . 6 . The reagent according to claim 5 , which is a reagent for producing a polynucleotide. 7 . A method for producing a single-stranded polynucleotide by a phosphoramidite method, the method comprising using the compound or a salt thereof or a solvate thereof according to claim 1 as an amidite monomer.
Processes for the preparation of sugar derivatives · CPC title
containing the ring system [IMAGE cpc-sch-C07F-1006.gif] having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs · CPC title
having the nitrogen atoms in positions 1 and 3 · CPC title
DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.